VCANBIO CELL & GENE ENGINEERING CORP., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.61 CNY | +3.49% |
|
-0.54% | -18.06% |
| 06-21 | Vcanbio Cell & Gene Engineering's Unit Gets Nod to Trial Stem Cell Drug | MT |
| 04-25 | Vcanbio Cell & Gene Engineering Corp., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 17.08 | 21.87 | 20.84 |
| Spread/Res. | -2.75% | -24.05% | -20.30% |
| Spread/Supp. | +3.81% | +24.14% | +13.53% |
| Support | 16.00 | 13.38 | 14.63 |
- Stock Market
- Equities
- 600645 Stock
- Charts Vcanbio Cell & Gene Engineering Corp., Ltd
